Constipation
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
No.9 September 2003
Vol.46, No.9 September 2003 CONTENTS Defecatory Dysfunction Pathogenesis and Pathology of Defecatory Disturbances Masahiro TAKANO . 367 Diagnosis of Impaired Defecatory Function with Special Reference to Physiological Tests Masatoshi OYA et al. 373 Surgical Management for Defecation Dysfunction Tatsuo TERAMOTO . 378 Dysfunction in Defecation and Its Treatment after Rectal Excision Katsuyoshi HATAKEYAMA . 384 Infectious Diseases Changes in Measures against Infectious Diseases in Japan and Proposals for the Future Takashi NOMURA et al. 390 Extragenital Infection with Sexually Transmitted Pathogens Hiroyuki KOJIMA . 401 Nutritional Counseling Behavior Therapy for Nutritional Counseling —In cooperation with registered dietitians— Yoshiko ADACHI . 410 Ⅵ Defecatory Dysfunction Pathogenesis and Pathology of Defecatory Disturbances JMAJ 46(9): 367–372, 2003 Masahiro TAKANO Director, Coloproctology Center, Hidaka Hospital Abstract: In recent years the number of patients with defecatory disturbances has increased due to an aging population, stress, and other related factors. The medical community has failed to focus enough attention on this condition, which remains a sort of psychosocial taboo, enhancing patient anxiety. Defecatory distur- bance classified according to cause and location can fall into one of four groups: 1) Endocrine abnormalities; 2) Disturbances of colonic origin that result from the long-term use of antihypertensive drugs or antidepressants or from circadian rhythm disturbances that occur with skipping breakfast or lower dietary -
The American Society of Colon and Rectal Surgeons' Clinical Practice
CLINICAL PRACTICE GUIDELINES The American Society of Colon and Rectal Surgeons’ Clinical Practice Guideline for the Evaluation and Management of Constipation Ian M. Paquette, M.D. • Madhulika Varma, M.D. • Charles Ternent, M.D. Genevieve Melton-Meaux, M.D. • Janice F. Rafferty, M.D. • Daniel Feingold, M.D. Scott R. Steele, M.D. he American Society of Colon and Rectal Surgeons for functional constipation include at least 2 of the fol- is dedicated to assuring high-quality patient care lowing symptoms during ≥25% of defecations: straining, Tby advancing the science, prevention, and manage- lumpy or hard stools, sensation of incomplete evacuation, ment of disorders and diseases of the colon, rectum, and sensation of anorectal obstruction or blockage, relying on anus. The Clinical Practice Guidelines Committee is com- manual maneuvers to promote defecation, and having less posed of Society members who are chosen because they than 3 unassisted bowel movements per week.7,8 These cri- XXX have demonstrated expertise in the specialty of colon and teria include constipation related to the 3 common sub- rectal surgery. This committee was created to lead inter- types: colonic inertia or slow transit constipation, normal national efforts in defining quality care for conditions re- transit constipation, and pelvic floor or defecation dys- lated to the colon, rectum, and anus. This is accompanied function. However, in reality, many patients demonstrate by developing Clinical Practice Guidelines based on the symptoms attributable to more than 1 constipation sub- best available evidence. These guidelines are inclusive and type and to constipation-predominant IBS, as well. The not prescriptive. -
Patient Information Leaflet
9 Tighten your anal muscles once more when Not everyone is the same, a normal bowel you have finished opening your bowels. habit varies from between three times a day to three times a week. Your motion should be solid, but easy to pass. If after following the advice in this leaflet Patient Information you are still having problems with Leaflet constipation please seek further help from your Doctor, Nurse or Continence Advisor. Compliments, comments, concerns or complaints? If you have any compliments, comments, concerns or complaints and you would like to speak to somebody about them please telephone or email If you find that your anal muscles are 01773 525119 tightening instead of relaxing practising 4, 5 [email protected] and 6 will help to get these muscles working correctly. However if you are still unable to Are we accessible to you? This publication relax your anal muscles and are straining is available on request in other formats (for excessively for long periods you should seek example, large print, easy read, Braille or help from your Doctor or Continence Advisor. audio version) and languages. For free You may have a condition known as anismus translation and/or other format please call which simply means that the muscles in your 01246 515224, or email us anus contract when they should relax. This is [email protected] easily treated. Remember... Constipation Advice for ¨ Drink 1.5-2 litres of fluid a day Continence Advisory Service Patients ¨ Eat 5 portions of fruit / vegetables a day Alfreton Primary Care Centre ¨ Eat regularly ¨ Never ignore the sensation to go Church Street Not everyone has a bowel which works ¨ Allow yourself plenty of time and privacy Alfreton properly, but you may be able to improve ¨ Get into a routine Derbyshire your symptoms by following the advice - Exercise (within your capabilities) DE55 7AH offered in this leaflet - Do not strain. -
The Efficacy of a Multidisciplinary Approach to the Management of Constipation: a Case Series
Journal of the Association of Chartered Physiotherapists in Women’s Health, Spring 2008, 102, 36–44 CLINICAL PAPER The efficacy of a multidisciplinary approach to the management of constipation: a case series R. W. C. Leung, B. K. Y. Fung & L. C. W. Fung Physiotherapy Department, Kwong Wah Hospital, Hong Kong W. C. S. Meng, P. Y. Y. Lau & A. W. C. Yip Department of Surgery, Kwong Wah Hospital, Hong Kong Abstract The aim of this study was to evaluate a rehabilitative programme including biofeedback training for the treatment of chronic constipation. A prospective series of patients with constipation, as defined by the Rome II diagnostic criteria, were assessed by a clinician, a dietitian and a physiotherapist. Anorectal physi- ology investigations and defecography were performed prior to and after the programme. The treatment involved consultation by the dietitian, postural re-education and pelvic floor re-education regarding the proper pattern of defecation. The subjects were followed up in alternate weeks for the first 3 months and then monthly for another 3 months. Twenty patients have been recruited into the programme since 2005. Ten subjects have completed the course of treatment and three have defaulted; the remaining seven were still undergoing treatment at the time of writing. On completion of the programme, there was a significant improvement in fibre intake (pre-treatment=12.9191.06 g; post-treatment= 20.2661.064 g; P=0.001), average straining effort (pre-treatment=6.360.391; post-treatment=3.720.391; P=0.001) and average straining time (pre- treatment=17.612.172 min; post-treatment=6.002.172 min; P=0.004). -
Effect of Single Dose Resin-Cathartic Therapy on Serum Potassium Concentration in Patients with End-Stage Renal Disease
J Am Soc Nephrol 9: 1924-1930. 1998 Effect of Single Dose Resin-Cathartic Therapy on Serum Potassium Concentration in Patients with End-Stage Renal Disease CHRISTINE GRUY-KAPRAL, MICHAEL EMMETT, CAROL A. SANTA ANA, JACK L. PORTER, JOHN S. FORDTRAN, and KENNETH D. FINE Departnzent of Internal Medicine, Baylor Universirs’ Medical Center, Dallas, Texas. Abstract. Hyperkalemia in patients with renal failure is fre- slightly (0.4 mEqIL) during the I 2-h experiment. This rise was quently treated with a cation exchange resin (sodium polysty- apparently abrogated by some of the regimens that included rene sulfonate, hereafter referred to as resin) in combination resin; this may have been due in part to extracellular volume with a cathartic, but the effect of such therapy on serum expansion caused by absorption of sodium released from resin. potassium concentration has not been established. This study Phenolphthalein regimens were associated with a slight rise in evaluates the effect of four single-dose resin-cathartic regimens serum potassium concentrations (similar to placebo); this may and placebo on 5 different test days in six patients with chronic have been due to extracellular volume contraction produced by renal failure. Dietary intake was controlled. Fecal potassium high volume and sodium-rich diarrhea and acidosis secondary output and serum potassium concentration were measured for to bicarbonate losses. None of the regimens reduced serum 12 h. Phenobphthalein alone caused an average fecal potassium potassium concentrations, compared with baseline levels. Be- output of 54 mEq. The addition of resin caused an increase in cause single-dose resin-cathartic therapy produces no or only insoluble potassium output but a decrease in soluble potassium trivial reductions in serum potassium concentration, and be- output; therefore, there was no significant effect of resin on cause this therapy is unpleasant and occasionally is associated total potassium output. -
Redalyc.Biofeedback Treatment in Chronically Constipated Patients
Revista Latinoamericana de Psicología ISSN: 0120-0534 [email protected] Fundación Universitaria Konrad Lorenz Colombia Simón, Miguel A.; Bueno, Ana M.; Durán, Montserrat Biofeedback treatment in chronically constipated patients with dyssynergic defecation Revista Latinoamericana de Psicología, vol. 43, núm. 1, 2011, pp. 105-111 Fundación Universitaria Konrad Lorenz Bogotá, Colombia Available in: http://www.redalyc.org/articulo.oa?id=80520078010 How to cite Complete issue Scientific Information System More information about this article Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Journal's homepage in redalyc.org Non-profit academic project, developed under the open access initiative Biofeedback on dyssynergic defecation Biofeedback treatment in chronically constipated patients with dyssynergic defecation Biofeedback aplicado al tratamiento de pacientes con estreñimiento crónico debido a defecación disinérgica Recibido: Marzo de 2009 Miguel A. Simón Aceptado: Agosto de 2010 Ana M. Bueno Montserrat Durán University of A Coruña, Department of Psychology, Research Group in Clinical and Health Psychology, Spain Correspondence: Miguel A. Simón, Full postal address: Research Group in Clinical and Health Psychology, Department of Psychology, University of A Coruña, Campus of Elviña, 15071 A Coruña, Spain Abstract Resumen The aim of this study was to evaluate the effects of El objetivo de este estudio fue evaluar los efectos del electromyographic biofeedback training in chronically entrenamiento -
3.2.2 Misuse of Stimulant Laxatives
Medicines Adverse Reactions Committee Meeting date 10/06/2021 Agenda item 3.2.2 Title Misuse of stimulant laxatives Submitted by Medsafe Pharmacovigilance Paper type For advice Team Active ingredient Product name Sponsor Bisacodyl Bisacodyl Laxative (Pharmacy Health) PSM Healthcare Limited trading as API tablet Consumer Brands Dulcolax tablet Sanofi-Aventis New Zealand Limited Dulcolax Suppository Sanofi-Aventis New Zealand Limited *Lax-Suppositories Bisacodyl AFT Pharmaceuticals Limited *Lax-Tab tablet AFT Pharmaceuticals Limited Docusate sodium *Coloxyl tablet Pharmacy Retailing (New Zealand) Limited trading as Healthcare Logistics Docusate sodium + Coloxyl with Senna tablet Pharmacy Retailing (New Zealand) sennosides Limited trading as Healthcare Logistics *Laxsol tablet Pharmacy Retailing (New Zealand) Limited trading as Healthcare Logistics Glycerol *Glycerol Suppositories PSM Healthcare Limited trading as API Consumer Brands Sennosides *Senokot tablet Reckitt Benckiser (New Zealand) Limited Sodium picosulfate Dulcolax SP Drops oral solution Sanofi-Aventis New Zealand Limited PHARMAC funding *Pharmaceutical Schedule Lax-Tab tablets, Lax-Suppositories Bisacodyl, Coloxyl tablets and Glycerol Suppositories are fully-funded only on a prescription. Senokot tablets are part- funded. Previous MARC Misuse of stimulant laxatives has not been discussed previously. meetings International action Following a national safety review published in August 2020, the MHRA in the UK has introduced pack size restrictions, revised recommended ages for use -
Assessment Report on Ricinus Communis L., Oleum Final
2 February 2016 EMA/HMPC/572973/2014 Committee on Herbal Medicinal Products (HMPC) Assessment report on Ricinus communis L., oleum Final Based on Article 10a of Directive 2001/83/EC as amended (well-established use) Herbal substance(s) (binomial scientific name Ricinus communis L., oleum (castor oil) of the plant, including plant part) Herbal preparation Fatty oil obtained from seeds of Ricinus communis L. by cold expression Pharmaceutical forms Herbal preparation in liquid or solid dosage forms for oral use Rapporteur C. Purdel Peer-reviewer B. Kroes 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact An agency of the European Union © European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged. Table of contents Table of contents ................................................................................................................... 2 1. Introduction ....................................................................................................................... 4 1.1. Description of the herbal substance(s), herbal preparation(s) or combinations thereof .. 4 1.2. Search and assessment methodology ..................................................................... 6 2. Data on medicinal use ........................................................................................................ 6 2.1. Information about products on the market ............................................................. -
Chronic Constipation: an Evidence-Based Review
J Am Board Fam Med: first published as 10.3122/jabfm.2011.04.100272 on 7 July 2011. Downloaded from CLINICAL REVIEW Chronic Constipation: An Evidence-Based Review Lawrence Leung, MBBChir, FRACGP, FRCGP, Taylor Riutta, MD, Jyoti Kotecha, MPA, MRSC, and Walter Rosser MD, MRCGP, FCFP Background: Chronic constipation is a common condition seen in family practice among the elderly and women. There is no consensus regarding its exact definition, and it may be interpreted differently by physicians and patients. Physicians prescribe various treatments, and patients often adopt different over-the-counter remedies. Chronic constipation is either caused by slow colonic transit or pelvic floor dysfunction, and treatment differs accordingly. Methods: To update our knowledge of chronic constipation and its etiology and best-evidence treat- ment, information was synthesized from articles published in PubMed, EMBASE, and Cochrane Database of Systematic Reviews. Levels of evidence and recommendations were made according to the Strength of Recommendation taxonomy. Results: The standard advice of increasing dietary fibers, fluids, and exercise for relieving chronic constipation will only benefit patients with true deficiency. Biofeedback works best for constipation caused by pelvic floor dysfunction. Pharmacological agents increase bulk or water content in the bowel lumen or aim to stimulate bowel movements. Novel classes of compounds have emerged for treating chronic constipation, with promising clinical trial data. Finally, the link between senna abuse and colon cancer remains unsupported. Conclusions: Chronic constipation should be managed according to its etiology and guided by the best evidence-based treatment.(J Am Board Fam Med 2011;24:436–451.) copyright. Keywords: Chronic Constipation, Clinical Review, Evidence-Based Medicine, Family Medicine, Gastrointestinal Problems, Systematic Review The word “constipation” has varied meanings for was established in 1991 by Drossman et al, primar- different individuals. -
Irritable Bowel Syndrome
Irritable Bowel Syndrome If you suffer from the following ongoing symptoms, you mostly because IBS is not limited to the large intestine (colon). might have IBS: Sometimes, IBS is confused with colitis or other inflammatory Abdominal Pain diseases of the intestinal tract, but the difference is clear – in Bloating IBS, inflammation does not seem to accompany symptoms. Constipation Diarrhea Symptoms IBS is a chronic, often debilitating, functional gastrointestinal Almost every person has experienced abdominal cramping, (GI) disorder with symptoms that include abdominal pain, bloating, constipation, or diarrhea at some point in his or her bloating, and altered bowel behaviours, such as constipation life. However, those who have IBS experience these multiple and/or diarrhea, or alternating between the two. In IBS, the symptoms more frequently and intensely, to the extent that they function, or movement, of the bowel is not quite right. There are interfere with day-to-day living. no medical tests to confirm or rule out a diagnosis and yet it is A person who has IBS likely has a sensitive digestive the most common GI condition worldwide and the most frequent system with heightened reactivity, so that the GI tract responds disorder presented by individuals consulting a gastrointestinal quite differently to normal gut stimuli, such as the passage of specialist (gastroenterologist). solids, gas, and fluid through the intestines. These unusual IBS can begin in childhood, adolescence, or adulthood and movements may result in difficulty passing stool, or sudden, can resolve unexpectedly for periods throughout an individual’s urgent elimination. Up to 20% of those who have IBS report lifespan, recurring at any age. -
European Evidence Based Consensus on Surgery for Ulcerative Colitis Tom Øresland*, Willem A
Journal of Crohn’s and Colitis, 2015, 4–25 doi:10.1016/j.crohns.2014.08.012 ECCO Guidelines/Consensus Paper ECCO Guidelines/Consensus Paper European evidence based consensus on surgery for ulcerative colitis Tom Øresland*, Willem A. Bemelman, Gianluca M. Sampietro, Antonino Spinelli, Alastair Windsor, Marc Ferrante, Philippe Marteau, Oded Zmora, Paulo Gustavo Kotze, Eloy Espin-Basany, Emmanuel Tiret, Giuseppe Sica, Yves Panis, Arne E. Faerden, Livia Biancone, Imerio Angriman, Zuzana Serclova, Anthony de Buck van Overstraeten, Paolo Gionchetti, Laurents Stassen, Janindra Warusavitarne Michel Adamina, Axel Dignass, Rami Eliakim, Fernando Magro, André D’Hoore, On behalf of the European Crohn's and Colitis Organisation (ECCO) Received July 14 2014; revised August 23 2014; accepted August 27 2014. ⁎Corresponding author at: Clinic for Surgical Sciences, Univ. of Oslo at Dept. of Digestive Surgery, Akershus Univ. Hospital, 1478 Lorenskog, Norway. Keywords: ulcerative colitis; surgery; ileal pouch-anal anastomosis; cancer 1. Introduction and also for all national representatives of ECCO for the second vot- ing procedure. The WGs finally met in Belgrade on September 25th The goal of this consensus initiated by the European Crohn's and 2013 for a final face-to-face discussion and to vote and consent on Colitis Organisation (ECCO) was to establish European consensus the statements. Technically this was done by projecting the statements guidelines for the surgical treatment of ulcerative colitis. The strategy and revising them on screen until a consensus was reached. Consensus to reach the consensus involved several steps and follows the standard was defined as agreement by more than 80% of participants, termed a operating procedures for consensus guidelines of ECCO. -
Irritable Bowel-Anismus
7-5 Irritable Bowel-Anismus Wael Solh and Eric G.Weiss The causes of constipation and altered defecation are mul- found in patients with solitary ulcer syndrome and idio- tifactorial, and the manifestations are varied. Etiologies of pathic perineal pain.3 Therefore, the diagnosis of NRPS must constipation or altered defecation can be divided into two be made based on the patient’s clinical findings, supported categories – slow transit constipation, and pelvic outlet by more than one physiologic investigation. obstruction. Pelvic outlet obstruction includes etiologies such as paradoxical or nonrelaxation of the puborectalis muscle or anismus (nonrelaxation of the “anal canal”), Treatment rectal prolapse or intussusception, and nonemptying rec- toceles. Associated findings may include perineal descent Because NRPS is a behavioral rather than an anatomic and solitary rectal ulcer syndrome. abnormality, biofeedback is the standard therapy. In In normal defecation, the pelvic floor muscles and exter- biofeedback training, patients are allowed to view their nal anal sphincter are voluntarily inhibited resulting in an own EMG or manometric tracings on a video monitor increase in the anorectal angle with increasing intraab- while attempting to relax the pelvic floor and sphincter dominal pressure. Patients with nonrelaxing puborectalis muscles. Numerous reports have demonstrated success syndrome (NRPS) or anismus are unable to voluntarily rates ranging from 37% to 100%.4 In the largest series to inhibit contraction of the pelvic floor. When inappropriate date, Gilliland and Wexner5 found only one variable to be function of the puborectalis muscle (inappropriate con- predictive of a successful outcome: patients who self- traction or failure to relax) results in the inability to evac- discharged from therapy had a success rate of only uate the rectum, the condition is termed anismus.